TGA Scheduling Interim Decision Wild Cherry Bark – amygdalin and hydrocyanic acid

The TGA has published the Scheduling interim decision on amygdalin and hydrocyanic acid, and a public consultation on the interim decision is now open, closing 2 November 2023

After considering the submissions from 36 entities, including CMA (10 submissions were opposed to the proposal) and advice of the joint Advisory Committee on Chemicals and Medicines Scheduling (ACCS- ACMS), the Delegate of the Secretary of the Department of Health and Aged Care has made an interim decision to not amend the current Poisons Standard in relation to amygdalin  and HCN.

Members are encouraged to read today’s technical alert for more information and details, including a summary of the Delegate’s reasons, relevant scheduling history, and how to respond to the interim decision consultation.

LinkedIn
Facebook
Twitter
Email

RECENT ARTICLES

Vale Stephen Myers

It is with great sadness that we learned of the passing of Emeritus Professor Stephen Myers late last week. Stephen was a giant in the

Read More